UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (922) 922
science & technology (817) 817
life sciences & biomedicine (792) 792
male (565) 565
female (538) 538
azacitidine - therapeutic use (482) 482
aged (478) 478
middle aged (461) 461
oncology (450) 450
azacitidine - analogs & derivatives (428) 428
azacitidine - adverse effects (411) 411
hematology (403) 403
azacitidine - administration & dosage (353) 353
myelodysplastic syndromes - drug therapy (331) 331
adult (308) 308
treatment outcome (286) 286
azacitidine (279) 279
antimetabolites, antineoplastic - therapeutic use (273) 273
azacitidine - pharmacology (243) 243
leukemia, myeloid, acute - drug therapy (239) 239
aged, 80 and over (238) 238
decitabine (222) 222
biological and medical sciences (204) 204
medical sciences (199) 199
antimetabolites, antineoplastic - adverse effects (190) 190
myelodysplastic syndromes (186) 186
antineoplastic agents (181) 181
dna methylation (179) 179
cancer (171) 171
dna methylation - drug effects (166) 166
chemotherapy (159) 159
myelodysplastic syndrome (159) 159
leukemia (153) 153
acute myeloid leukemia (152) 152
antineoplastic combined chemotherapy protocols - therapeutic use (145) 145
animals (136) 136
care and treatment (135) 135
prognosis (131) 131
antimetabolites, antineoplastic - administration & dosage (123) 123
methylation (119) 119
research (116) 116
antimitotic agents (102) 102
drug administration schedule (102) 102
hematology, oncology and palliative medicine (102) 102
analysis (101) 101
hematologic and hematopoietic diseases (99) 99
medicine & public health (98) 98
antineoplastic combined chemotherapy protocols - adverse effects (97) 97
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (95) 95
pharmacology. drug treatments (95) 95
myelodysplastic syndromes - mortality (93) 93
retrospective studies (90) 90
tumors (90) 90
epigenetics (89) 89
remission induction (87) 87
pharmacology & pharmacy (85) 85
leukemia, myeloid, acute - mortality (84) 84
survival analysis (84) 84
dose-response relationship, drug (81) 81
adolescent (78) 78
antineoplastic agents - therapeutic use (77) 77
cell line, tumor (77) 77
myelodysplastic syndromes - genetics (74) 74
stem cells (74) 74
abridged index medicus (73) 73
gene expression (73) 73
transplantation (73) 73
clinical trials as topic (72) 72
myelodysplastic syndromes - therapy (72) 72
drug therapy (71) 71
leukemia, myeloid, acute - genetics (71) 71
myelodysplastic syndromes - pathology (70) 70
risk factors (70) 70
health aspects (69) 69
leukemia, myeloid, acute - pathology (68) 68
antimetabolites, antineoplastic - pharmacology (67) 67
mice (67) 67
young adult (67) 67
patients (64) 64
deoxyribonucleic acid--dna (63) 63
myelodysplastic syndromes - diagnosis (63) 63
survival rate (61) 61
clinical trials (58) 58
antineoplastic agents - adverse effects (57) 57
cell biology (57) 57
dna modification methylases - antagonists & inhibitors (57) 57
dna (55) 55
drug therapy, combination (55) 55
genetic aspects (55) 55
disease-free survival (54) 54
mutation (54) 54
hemic and lymphatic diseases (52) 52
medical research (51) 51
recurrence (49) 49
mds (48) 48
kaplan-meier estimate (47) 47
hypomethylating agents (46) 46
disease progression (45) 45
drug evaluation (45) 45
leukemia, myeloid, acute - therapy (45) 45
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1050) 1050
Chinese (6) 6
French (4) 4
Italian (3) 3
Japanese (3) 3
German (2) 2
Spanish (2) 2
Hebrew (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British journal of haematology, ISSN 0007-1048, 11/2014, Volume 167, Issue 3, pp. 356 - 365
clinical trial | DNA methylation | decitabine | precursor cell lymphoblastic leukaemia‐Lymphoma | Clinical trial | Decitabine | Precursor cell lymphoblastic leukaemia-Lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Recurrence | Azacitidine - adverse effects | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | DNA, Neoplasm - chemistry | Antimetabolites, Antineoplastic - administration & dosage | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Hyperglycemia - chemically induced | Vincristine - administration & dosage | Adult | Female | Child | Chemical and Drug Induced Liver Injury - etiology | Azacitidine - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Azacitidine - analogs & derivatives | Remission Induction | Cytarabine - administration & dosage | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Adolescent | Antimetabolites, Antineoplastic - adverse effects | Vincristine - adverse effects | Methotrexate - administration & dosage | Aged | Infusions, Intravenous | DNA Methylation - drug effects | Doxorubicin - adverse effects | Gastrointestinal Diseases - chemically induced | Azacitidine - therapeutic use | Index Medicus | DNA Methylation | Precursor Cell Lymphoblastic Leukaemia-Lymphoma | Clinical Trial
Journal Article
Blood, ISSN 0006-4971, 09/2018, Volume 132, Issue 11, pp. 1125 - 1133
Journal Article
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 10/2014, Volume 74, Issue 4, pp. 691 - 697
Resistance | Hypomethylation | Medicine & Public Health | Melanoma | Epigenetics | Oncology | Cancer Research | Epigenetic priming | Histone deacetylation | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Tumors of the skin and soft tissue. Premalignant lesions | Dermatology | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Azacitidine - adverse effects | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | DNA Modification Methylases - antagonists & inhibitors | Humans | Hydroxamic Acids - adverse effects | Middle Aged | Histone Deacetylase Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Indoles - administration & dosage | Dose-Response Relationship, Drug | Eye Neoplasms - drug therapy | Dacarbazine - analogs & derivatives | Hydroxamic Acids - administration & dosage | Female | Azacitidine - administration & dosage | Melanoma - physiopathology | Skin Neoplasms - pathology | Dacarbazine - administration & dosage | Epigenomics | Eye Neoplasms - pathology | Azacitidine - analogs & derivatives | Treatment Outcome | Melanoma - pathology | Eye Neoplasms - physiopathology | Skin Neoplasms - physiopathology | Maximum Tolerated Dose | Indoles - adverse effects | Melanoma - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Drug Monitoring | Histone Deacetylase Inhibitors - adverse effects | Drug Resistance, Neoplasm - drug effects | Drug Screening Assays, Antitumor | Antimitotic agents | Epigenetic inheritance | Usage | Chemotherapy | Transferases | Resveratrol | Development and progression | Metastasis | Drug therapy | Cancer | Index Medicus | Original
Journal Article
Chemico-biological interactions, ISSN 0009-2797, 10/2016, Volume 258, pp. 21 - 29
Journal Article
British journal of haematology, ISSN 0007-1048, 02/2016, Volume 172, Issue 3, pp. 384 - 391
Journal Article